Cargando…
Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be aff...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274427/ https://www.ncbi.nlm.nih.gov/pubmed/27854291 http://dx.doi.org/10.3390/molecules21111542 |
_version_ | 1783377615736799232 |
---|---|
author | Luna, Omar F. Gomez, Johana Cárdenas, Constanza Albericio, Fernando Marshall, Sergio H. Guzmán, Fanny |
author_facet | Luna, Omar F. Gomez, Johana Cárdenas, Constanza Albericio, Fernando Marshall, Sergio H. Guzmán, Fanny |
author_sort | Luna, Omar F. |
collection | PubMed |
description | The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be affected by side reactions and by-product formation. Several aspects have to be taken into consideration when selecting a deprotection reagent: its physicochemical behavior, basicity (pKa) and polarity, concentration, and time of reaction, toxicity and disposability of residues and, finally, availability of reagents. This report presents a comparison of the performance of three strategies for deprotection using microwave-assisted Fmoc peptide synthesis. Four peptide sequences were synthesized using Rink amide resin with a Liberty Blue™ automated synthesizer and 4-methylpiperidine (4MP), piperidine (PP), and piperazine (PZ) as Fmoc removal reagents. In the first instance all three reagents behaved similarly. A detailed analysis showed a correlation between the hydrophobicity and size of the peptide with the yield and purity of the obtained product. The three reagents are interchangeable, and replacement of piperidine could be advantageous regarding toxicity and reagent handling. |
format | Online Article Text |
id | pubmed-6274427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62744272018-12-28 Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? Luna, Omar F. Gomez, Johana Cárdenas, Constanza Albericio, Fernando Marshall, Sergio H. Guzmán, Fanny Molecules Article The deprotection step is crucial in order to secure a good quality product in Fmoc solid phase peptide synthesis. 9-Fluorenylmethoxycarbonyl (Fmoc) removal is achieved by a two-step mechanism reaction favored by the use of cyclic secondary amines; however, the efficiency of the reaction could be affected by side reactions and by-product formation. Several aspects have to be taken into consideration when selecting a deprotection reagent: its physicochemical behavior, basicity (pKa) and polarity, concentration, and time of reaction, toxicity and disposability of residues and, finally, availability of reagents. This report presents a comparison of the performance of three strategies for deprotection using microwave-assisted Fmoc peptide synthesis. Four peptide sequences were synthesized using Rink amide resin with a Liberty Blue™ automated synthesizer and 4-methylpiperidine (4MP), piperidine (PP), and piperazine (PZ) as Fmoc removal reagents. In the first instance all three reagents behaved similarly. A detailed analysis showed a correlation between the hydrophobicity and size of the peptide with the yield and purity of the obtained product. The three reagents are interchangeable, and replacement of piperidine could be advantageous regarding toxicity and reagent handling. MDPI 2016-11-15 /pmc/articles/PMC6274427/ /pubmed/27854291 http://dx.doi.org/10.3390/molecules21111542 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Luna, Omar F. Gomez, Johana Cárdenas, Constanza Albericio, Fernando Marshall, Sergio H. Guzmán, Fanny Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title | Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title_full | Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title_fullStr | Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title_full_unstemmed | Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title_short | Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine? |
title_sort | deprotection reagents in fmoc solid phase peptide synthesis: moving away from piperidine? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274427/ https://www.ncbi.nlm.nih.gov/pubmed/27854291 http://dx.doi.org/10.3390/molecules21111542 |
work_keys_str_mv | AT lunaomarf deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine AT gomezjohana deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine AT cardenasconstanza deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine AT albericiofernando deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine AT marshallsergioh deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine AT guzmanfanny deprotectionreagentsinfmocsolidphasepeptidesynthesismovingawayfrompiperidine |